Innovation
1 patent family — focus: Chemistry & metallurgy; filing pace active. Cited 7 times.
| Year | Filings |
|---|---|
| 2024 | 1 |
| 2025 | 1 |
Investor mix
5 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 80% |
| Other / undisclosed | 1 | 20% |
Provides drug discovery using cell-free membrane protein preparation and unnatural amino acid
1 patent family — focus: Chemistry & metallurgy; filing pace active. Cited 7 times.
| Year | Filings |
|---|---|
| 2024 | 1 |
| 2025 | 1 |
5 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 80% |
| Other / undisclosed | 1 | 20% |